Abstract
Ceftaroline fosamil, a new broad-spectrum cephalosporin, exhibits potent bactericidal activity against common Gram-negative pathogens, including Enterobacteriaceae, and Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. The purpose of this study was to evaluate the efficacy of a human simulated dose of ceftaroline fosamil against clinical Enterobacteriaceae in both neutropenic and immunocompetent mouse thigh infection models. Thirty-five Enterobacteriaceae isolates with ceftaroline MICs ranging from 0.25 to 32 μg/ml were selected for the neutropenic model, and five Escherichia coli isolates were also tested in the immunocompetent model. Two hours after inoculation, the ceftaroline fosamil human simulated regimen of 600 mg intravenously (i.v.) every 12 h was administered. The change in log(10) CFU after 24 h was compared to that in 0 h controls. The human simulated regimen produced predictable efficacy against 18 of 20 isolates with a MIC of ≤ 1 μg/ml. Similar efficacy was seen in the immunocompetent model against isolates with a MIC of ≤ 2 μg/ml, and enhanced efficacy was observed against the isolate with a MIC of 4 μg/ml. Human simulated exposures t...Continue Reading
References
Aug 11, 1997·Archives of Internal Medicine·B J MarstonR F Breiman
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Turnidge
Sep 16, 1998·Antimicrobial Agents and Chemotherapy·D Andes, W A Craig
Feb 10, 2000·American Journal of Public Health·D R FeikinJ H Jorgensen
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanUNKNOWN American Thoracic Society
May 6, 2003·Diagnostic Microbiology and Infectious Disease·Daryl J HobanRonald N Jones
Mar 20, 2004·Nature Reviews. Microbiology·George L Drusano
Jan 10, 2006·Drugs·C Andrew DeRykeDavid P Nicolau
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·D Andes, W A Craig
Sep 2, 2006·Pharmacotherapy·Thomas P LodiseUNKNOWN Society of Infectious Diseases Pharmacists
Oct 25, 2006·Diagnostic Microbiology and Infectious Disease·Gary J MoetThomas R Fritsche
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Jared L CrandonDavid P Nicolau
Mar 11, 2010·MCN. the American Journal of Maternal Child Nursing·Sharron Forest
Nov 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas M FileDirk Thye
Dec 9, 2010·The Journal of Antimicrobial Chemotherapy·Ronald N JonesHelio S Sader
Dec 9, 2010·The Journal of Antimicrobial Chemotherapy·G Ralph CoreyUNKNOWN CANVAS 1 investigators
Dec 9, 2010·The Journal of Antimicrobial Chemotherapy·Mark H WilcoxUNKNOWN CANVAS 2 investigators
Apr 26, 2011·The Journal of Antimicrobial Chemotherapy·Thomas M FileUNKNOWN FOCUS 1 investigators
Apr 26, 2011·The Journal of Antimicrobial Chemotherapy·Donald E LowUNKNOWN FOCUS 2 investigators
Apr 22, 2011·The Journal of Antimicrobial Chemotherapy·Ronald N JonesHelio S Sader
Apr 27, 2011·Antimicrobial Agents and Chemotherapy·Dora E WiskirchenDavid P Nicolau
Jun 15, 2011·Antimicrobial Agents and Chemotherapy·Rebecca A KeelDavid P Nicolau
Citations
Jun 27, 2013·Drugs·James E Frampton
Jul 12, 2012·Drugs·Thomas P Lodise, Donald E Low
Feb 6, 2016·The Journal of Antimicrobial Chemotherapy·Karen E BowkerAlasdair P MacGowan
Oct 22, 2016·Drugs·Lesley J Scott
Sep 4, 2014·Arquivos Brasileiros De Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery·Paula Virginia Michelon ToledoAyrton Alves Aranha-Junior
Feb 6, 2014·Expert Review of Clinical Pharmacology·Eric BeresfordH David Friedland
Mar 30, 2017·Journal of Pharmacokinetics and Pharmacodynamics·Catharine C BulikPaul G Ambrose